Beatrice Caruso

发表

Investigative Clinical Study on Prostate Cancer Part IV: Exploring Functional Relationships of Total Testosterone Predicting Free Testosterone and Total Prostate-Specific Antigen in Operated Prostate Cancer Patients

F. Migliorini, T. Sava, M. Romano, 2011, Urologia Internationalis.

High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical Prostatectomy

M. Brunelli, W. Artibani, I. Tamanini, 2016, Urologia Internationalis.

Prostate cancer volume associates with preoperative plasma levels of testosterone that independently predicts high grade tumours which show low densities (quotient testosterone/tumour volume)

F. Migliorini, M. Brunelli, W. Artibani, 2015, Asian journal of urology.

Associations of Pretreatment Serum Total Testosterone Measurements with Pathology-Detected Gleason Score Cancer

F. Migliorini, W. Artibani, T. Sava, 2013, Urologia Internationalis.

Serum Total Testosterone Is a Significant Preoperative Variable Independently Contributing to Separating the Prostate Cancer Population into Prostatectomy Gleason Score Groups

F. Migliorini, W. Artibani, T. Sava, 2013, Urologia Internationalis.

Investigative Clinical Study on Prostate Cancer Part III: Exploring Total PSA and Free Testosterone Distributions and Linear Correlations in Groups and Subgroups of Operated Prostate Cancer Patients according to the Total PSA/FT Ratio

F. Migliorini, T. Sava, M. Romano, 2010, Urologia Internationalis.

Investigative clinical study on prostate cancer: on the role of the pretreatment total PSA to free testosterone ratio in selecting different biology groups of prostate cancer patients

F. Migliorini, T. Sava, M. Romano, 2010, International Urology and Nephrology.

Along the pituitary-testis-prostate axis, serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups.

F. Migliorini, W. Artibani, T. Sava, 2012, Anticancer research.

Clinical Study on Prostate Cancer Part IX and X : Estradiol and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis and Subsequent Cluster Selection of the Patient Population after Radical Prostatectomy

F. Migliorini, T. Sava, M. Romano, 2012 .

Clinical Study on Prostate Cancer Part VIII : Prolactin Hormone and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis and Subsequent Cluster Selection of the Patient Population after Radical Prostatectomy

F. Migliorini, T. Sava, M. Romano, 2012 .

Investigative clinical study on prostate cancer part VII: prolactin and the pituitary-testis-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.

F. Migliorini, T. Sava, M. Romano, 2011, Anticancer research.

Follicle-Stimulating Hormone and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis of Prostate Cancer and Subsequent Cluster Selection of the Patient Population Undergoing Standard Radical Prostatectomy

F. Migliorini, T. Sava, M. Romano, 2012, Urologia Internationalis.

Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy.

F. Migliorini, T. Sava, M. Romano, 2012, Anticancer research.

Investigative Clinical Study on Prostate Cancer Part VI: Follicle-Stimulating Hormone and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis and Subsequent Cluster Selection of the Patient Population

F. Migliorini, T. Sava, M. Romano, 2011, Urologia Internationalis.

Investigative clinical study on prostate cancer Part V: Luteinizing hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.

F. Migliorini, T. Sava, M. Romano, 2011, Anticancer research.

Investigative Clinical Study on Prostate Cancer Part II: On the Role of the Pretreatment Total PSA to Free Testosterone Ratio as a Marker Assessing Prostate Cancer Prognostic Groups after Radical Retropubic Prostatectomy

Luigi Comunale, Claudio Ghimenton, Filippo Migliorini, 2010, Urologia Internationalis.

The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy.

M. Brunelli, W. Artibani, G. Cacciamani, 2016, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.